Showing results (341-350 of 367) with videos related to

Sort By:
Pageof 37
Science Advances|September 27, 2024
Combined assembloid modeling and 3D whole-organ mapping captures the microanatomy and function of the human fallopian tubeAshleigh J Crawford, André Forjaz, Joanna Bons, et al.
Gynecologic Oncology|March 7, 2024
Mutations in cancer-relevant genes are ubiquitous in histologically normal endometrial tissueDeep Pandya, Shannon Tomita, Maria Padron Rhenals, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2023
Combination ATR (ceralasertib) and PARP (olaparib) Inhibitor (CAPRI) Trial in Acquired PARP Inhibitor-Resistant Homologous Recombination-Deficient Ovarian CancerStephanie L Wethington, Payal D Shah, Lainie Martin, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 17, 2023
Low-grade serous ovarian cancer: expert consensus report on the state of the scienceRachel N Grisham, Brian M Slomovitz, Nicole Andrews, et al.
Cancer Research|August 30, 2020
Inhibition of the MYC-Regulated Glutaminase Metabolic Axis Is an Effective Synthetic Lethal Approach for Treating Chemoresistant Ovarian CancersYao-An Shen, Jiaxin Hong, Ryoichi Asaka, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 21, 2020
Assessing aneuploidy with repetitive element sequencingChristopher Douville, Joshua D Cohen, Janine Ptak, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 6, 2017
Epigenetic therapy activates type I interferon signaling in murine ovarian cancer to reduce immunosuppression and tumor burdenMeredith L Stone, Katherine B Chiappinelli, Huili Li, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|March 10, 2018
International Society of Gynecological Pathologists (ISGyP) Endometrial Cancer Project: Guidelines From the Special Techniques and Ancillary Studies GroupKathleen R Cho, Kumarasen Cooper, Sabrina Croce, et al.
Gynecologic Oncology|October 8, 2021
Combination ATR and PARP Inhibitor (CAPRI): A phase 2 study of ceralasertib plus olaparib in patients with recurrent, platinum-resistant epithelial ovarian cancerPayal D Shah, Stephanie L Wethington, Cheyenne Pagan, et al.
Cancers|September 9, 2022
Lung Cancer Recurrence Risk Prediction through Integrated Deep Learning EvaluationPeng Huang, Peter B Illei, Wilbur Franklin, et al.
Pageof 37